Patents
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
04/2004
04/29/2004US20040082625 Osteoporosis, bone disorders
04/29/2004US20040082580 Autoimmune diseases; antiinflammatory agents
04/29/2004US20040082576 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics
04/29/2004US20040082553 Novel florfenicol-type antibiotics
04/29/2004US20040082496 For the treatment of body weight disorders (obesity/anorexia/ bulemia/cachexia)
04/28/2004EP1412335A2 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
04/28/2004EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
04/28/2004EP1234819B1 Processes for production of oxadiazoline derivatives
04/28/2004EP1150962B1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds from carbamate compounds
04/28/2004EP0403618B2 Methyl esters of aldimino- or ketimino-oxy-ortho-tolylacrylic acid, manufacturing process and fungicides containing them
04/28/2004CN1492871A Isoxazoline derivatives as anti-depressants
04/27/2004US6727360 Coupling phenylmetaboric acid with 4-iodoisoxazole in presence of (1,1'-bis(diphenylphosphino)ferrocene) palladium (ii) chloride, sodium bicarbonate and solvent
04/27/2004US6727273 Therapy for osteoporosis, anticancer agents
04/27/2004US6727272 Leflunomide analogs for treating rheumatoid arthritis
04/22/2004WO2004033419A1 Sulfonamides having antiangiogenic and anticancer activity
04/22/2004WO2004033411A1 Process for producing enone ester
04/22/2004WO2003041728A9 Novel phenyl-propargylether derivatives
04/22/2004US20040077701 Pyrazole derivates for treatment of osteoporosis, breast and endometrial cancers, atherosclerosis, and Alzheimer*s disease
04/22/2004US20040077633 N-Heterocyclic derivatives; picornavirus infections in mammals; human rhinovirus
04/22/2004CA2501520A1 Sulfonamides having antiangiogenic and anticancer activity
04/21/2004EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
04/21/2004EP0900795B1 Benzene derivatives substituted by heterocycles and herbicides
04/21/2004CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical
04/21/2004CN1491207A Acylated indanyl amines and their use as pharmaceuticals
04/21/2004CN1146548C Isoxazolyl-and isoxazolinyl-substituted benzoylcyclohexanediones, production method and use thereof as herbicides and plant growth regulators
04/21/2004CN1146542C Benzamide derivatives and their use as cytokine inhibitors
04/21/2004CN1146536C Cycloethylene derivatives
04/20/2004US6723855 Chlorinating 5-methylisoxazole-4-carboxylic acid by reacting with chlorinating agent to form 5-methylisoxazole-4-carboxylic acid chloride, reacting with 4-trifluoromethylaniline in presence of alkali metal or alkaline earth metal bicarbonate
04/20/2004US6723724 Isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof
04/15/2004WO2004031139A1 Cyclohexyl sulphones as gamma-secretase inhibitors
04/15/2004WO2004031138A1 Novel sulphones for inhibition of gamma secretase
04/15/2004WO2004020445A3 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
04/15/2004US20040073029 Oxygen or sulfur containing heteroaromatics as factor Xa inhibitors
04/15/2004US20040072907 Antipicornaviral compounds, compositions containing them, and methods for their use
04/15/2004US20040072880 Cycloalkyl inhibitors of potassium channel function
04/15/2004US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders
04/15/2004CA2500969A1 Cyclohexyl sulphones as gamma-secretase inhibitors
04/15/2004CA2500966A1 Novel sulphones for inhibition of gamma secretase
04/14/2004EP1406889A2 Interaction inhibitors of tcf-4 with beta-catenin
04/14/2004EP1406884A1 Arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
04/14/2004EP1406870A1 Taxol enhancer compounds
04/14/2004EP1406869A1 Taxol enhancer compounds
04/14/2004EP1406868A1 Synthesis of taxol enhancers
04/14/2004EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
04/14/2004EP0921800B1 Substituted biphenyl isoxazole sulfonamides
04/14/2004CN1489576A Cannabinod receptor ligands
04/08/2004WO2004011444A3 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives
04/08/2004WO2003070690A3 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
04/08/2004WO2003057225A3 Phosphate transport inhibitors
04/08/2004US20040068012 Anticancer agents; protease enzyme inhibitor
04/08/2004US20040067908 Using lysophosphatidic acid receptor controllers
04/08/2004US20040065870 Organic dye molecules and nonlinear optical polymeric compounds containing chromophores
04/08/2004US20040065869 Organic dye molecules and nonlinear optical polymeric compounds containing chromophores
04/07/2004EP1405636A1 Function regulator for retinoid relative receptor
04/06/2004US6716989 Cyclization of a benzyloxime with branched alkene or of a benzalkylaldehyde with hydroxylamine and sulfiding
04/06/2004CA2095658C Agrochemical compositions and methods employing 3-hydroxy-5-methylisoxazole
04/06/2004CA2067381C Treatment of hiv infections and compounds useful therein
04/01/2004WO2004026823A1 Amide and sulfonamide ligands for the estrogen receptor
04/01/2004US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes
04/01/2004US20040063772 1-(4-fluoro-3-cyanophenyl)-3-trifluoromethyl-5-pyrazolecarboxylic acid, 1-(4-fluoro-3-cyanophenyl)-3-trifluoromethyl-5-(2-furyl)pyrazole, and imidazole
04/01/2004US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
04/01/2004CA2499490A1 Amide and sulfonamide ligands for the estrogen receptor
03/2004
03/31/2004EP1403247A1 N-Alkanoylphenylalanine derivatives
03/31/2004EP1240163B1 3-(4,5-dihydroisoxazole-5-yl)benzoylpyrazole
03/31/2004CN1143675C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
03/30/2004US6713507 Ether compounds and compositions for cholesterol management and related uses
03/25/2004WO2004024939A2 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
03/25/2004WO2004024687A1 Benzoyl compounds having imino group and herbicides
03/25/2004WO2004024676A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
03/25/2004WO2003086287A3 Compounds and methods for inducing apoptosis in proliferating cells
03/25/2004WO2003041728A8 Novel phenyl-propargylether derivatives
03/25/2004US20040059123 Methods for the preparation of biphenyl isoxazole sulfonamides
03/25/2004US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
03/25/2004CA2498045A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
03/24/2004EP1400516A1 Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals, and their usage
03/24/2004EP1400515A1 Cyclic diamine compound having five-membered cyclic group
03/24/2004EP1399423A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds
03/24/2004EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
03/24/2004EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity
03/24/2004EP0904079B1 Antidiabetic agents
03/24/2004CN1142912C Amide derivs, useful as inhibitors for production of cytokines
03/18/2004WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004WO2004021997A2 Inhibitors of fungal invasion
03/18/2004WO2004021984A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
03/18/2004WO2003099192A3 Bis-aromatic alkanols
03/18/2004US20040054172 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
03/18/2004US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders
03/18/2004US20040053985 Such as 1-(1-cyclooctyl-3-((nitrooxy)methyl)pyrazol-5-yl)-4-(methylsulfonyl)benzene; for synthesis of nitric oxide/ endothelium-derived relaxing factor; antiinflammatory agents; kits
03/18/2004US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
03/18/2004DE10244080A1 Amine and aminoxy compounds, useful for treating e.g. cancer or inflammation, are modulators of glycolytic enzymes or the transaminase complex
03/18/2004CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/17/2004EP1397136A1 Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents
03/17/2004EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
03/16/2004US6706886 Process and novel intermediates for preparing isoxazolin-3-ylacyl benzenes
03/16/2004US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/16/2004US6706729 A method for dissociating a metal ion from a zinc finger-containing protein; inhibiting virus
03/11/2004WO2004020445A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
03/11/2004WO2004020419A1 Novel sulfonation method for zonisamide intermediate in zonisamide synthesis and their novel crystal forms
03/11/2004WO2004020393A1 Dibenzylamine compound and medicinal use thereof
03/11/2004WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 115